抗CXCL5抗体(Anti-CXCL5, Human, Goat-Poly, Biotin antibody)

掲載日情報:2021/01/28 現在Webページ番号:29090

CXCL5に対する抗体(Anti-CXCL5, Human, Goat-Poly, Biotin )です。
本製品は研究用です。研究用以外には使用できません。

価格

[在庫・価格 :2025年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。
詳細 商品名
  • 商品コード
  • メーカー
  • 包装
  • 価格
  • 在庫
  • 法規制等
納期 文献数
Anti-CXCL5, Human, Goat-Poly, Biotin <Anti-ENA-78>
10日程度 ※ 表示されている納期は弊社に在庫がなく、取り寄せた場合の目安納期となります。 3
  • 使用文献
  • メーカーサイト
  • お問い合わせ
説明文
マッチドペア:Human CXCL5/ENA-78 サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB654-500,スタンダードとして#254-XB-025を用いる。
別名:CXCL5,ENA-78
Genbank No: 6374
Protein Accession No: P42830
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Goat クラス IgG 標識 Biotin
交差性 Human 適用 ELISA,Western Blot
クロナリティ Polyclonal フォーマット 性状 Antigen Affinity Purified 吸収処理
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド

[在庫・価格 :2025年04月26日 20時55分現在]

※ 表示されている納期は弊社に在庫が無く、取り寄せた場合の納期目安となります。

Anti-CXCL5, Human, Goat-Poly, Biotin <Anti-ENA-78>

文献数: 3

説明文 マッチドペア:Human CXCL5/ENA-78 サンドイッチELISAの検出用抗体として利用可能,補足用抗体として#MAB654-500,スタンダードとして#254-XB-025を用いる。
別名:CXCL5,ENA-78
Genbank No: 6374
Protein Accession No: P42830
法規制等
保存条件 -20℃ 法規備考
抗原種 Human 免疫動物 Goat
交差性 Human 適用 ELISA,Western Blot
標識 Biotin 性状 Antigen Affinity Purified
吸収処理 クラス IgG
クロナリティ Polyclonal フォーマット
掲載カタログ

製品記事 M1/M2 Macrophage Activation Marker
関連記事 R&D Systems(R&Dシステムズ)社 ELISA用ペア抗体を使用したELISA 構築ガイド



目次に戻る

Product Details

Species ReactivityHuman
LabelBiotin
ImmunogenE. coli-derived recombinant human CXCL5/ENA-78Ala37-Asn114Accession # P42830
SourcePolyclonal Goat IgG
PurificationAntigen Affinity-purified
SpecificityDetects human ENA-78 in ELISAs and Western blots. In sandwich immunoassays, less than 0.2% cross-reactivity with rhGCP-2 is observed and less than 0.05% cross-reactivity with rmGCP-2, rhGRO alpha, rrCINC-1, rmKC, rhNAP-2 and rhIL-8 is observed.


目次に戻る

Applications and Data

 Recommended
Concentration
Sample
Western Blot0.1 µg/mLRecombinant Human CXCL5/ENA‑78 (Catalog # 254-XB)
Human CXCL5/ENA-78 Sandwich ImmunoassayReagent
ELISA Capture (Matched Antibody Pair)2-8 µg/mL Human CXCL5/ENA‑78 Antibody (Catalog #MAB654 )
ELISA Detection (Matched Antibody Pair)0.1-0.4 µg/mL Human CXCL5/ENA‑78 Biotinylated Antibody (Catalog #BAF254 )
ELISA Standard  Recombinant Human CXCL5/ENA-78 Protein (Catalog #254-XB )
Please Note: Optimal dilutions should be determined by each laboratory for each application.General Protocolsare available in the Technical Information section on our website.Preparation and Storage
ReconstitutionReconstitute at 0.2 mg/mL in sterile PBS.Reconstitution Buffer Available
ShippingThe product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & StorageUse a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: CXCL5/ENA-78

CXCL5, also known as epithelial cell-derived neutrophil-activating peptide (ENA-78), is an 8 kDa proinflammatory member of the CXC subfamily of chemokines. Its Glu-Leu-Arg (ELR) motif confers angiogenic properties and distinguishes it from ELR-CXC chemokines which are angiostatic (1 - 3). Human CXCL5 shares 57% amino acid (aa) sequence identity with mouse and rat CXCL5. Among other human ELR+ chemokines, it shares 77% aa sequence identity with CXCL6/GCP-2 and 35% - 51% with CXCL1/GRO alpha, CXCL2/GRO beta, CXCL3/GRO gamma, CXCL7/NAP-2, and CXCL8/IL-8. Inflammatory stimulation upregulates CXCL5 production in multiple hematopoietic cell types, fibroblasts, endothelial cells, and vascular smooth muscle cells. In vivo, CXCL5 is elevated at sites of inflammation and pulmonary fibrosis where it promotes neutrophil infiltration and activation as well as angiogenesis (3 - 6). Its upregulation contributes to increased vascularization, tumor growth, and metastasis in many cancers (6 - 9). Full length CXCL5 (78 aa) is trimmed at the N-terminus by cathepsin G and chymotrypsin to ENA-74 (74 aa) and ENA-70 (70 aa), with the shortened forms showing increased potency relative to full length CXCL5 (10, 11). CXCL5 exerts its effects primarily through interactions with CXCR2 (6, 12). It also binds duffy antigen receptor for chemokines (DARC), which can limit CXCR2-mediated responses (13, 14).

目次に戻る

References

Strieter, R.M. et al. (2005) Cytokine Growth Factor Rev. 16:593.
Balestrieri, M.L. et al. (2008) Cardiovasc. Res. 78:250.
Walz, A.. et al. (1991) J. Exp. Med. 174:1355.
Strieter, R.M. et al. (1992) Immunol. Invest. 21:549.
Koch, A.E. et al. (1994) J. Clin. Invest. 94:1012.
Begley, L.A. et al. (2008) Neoplasia 10:244.
Vandercappellen, J. et al. (2008) Cancer Lett. 267:226.
Arenberg, D.A. et al. (1998) J. Clin. Invest. 102:465.
Miyazaki, H. et al. (2006) Cancer Res. 66:4279.
Wuyts, A. et al. (1999) Eur. J. Biochem. 260:421.
Nufer, O. et al. (1999) Biochemistry 38:636.
Ahuja, S.K. and P.M. Murphy (1996) J. Biol. Chem. 271:20545.
Kashiwazaki, M. et al. (2003) Int. Immunol. 15:1219.
Horton, L.W. et al. (2007) Cancer Res. 67:9791.
Entrez Gene IDs:6374 (Human)
Alternate Names:CXCL5; CXCL5/ENA-78; ENA78; ENA-78

目次に戻る

Related Research Areas

Alpha Granule Soluble Molecules
Chemokines and Receptors
Chemokines and Receptors in Angiogenesis
CXC Chemokines and Receptors
Macrophage Activation Markers
  1. Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells.
    Authors: Edwards MR, Johnson MW, Johnston SL
    Am. J. Respir. Cell Mol. Biol., 2006;34(5):616-24.
    Species: Human
    Sample Type: Cell Culture Supernates
    Application: ELISA Development


目次に戻る

Related Product & Information

BackgroundCXCL5/ENA-78
background_contentBackground:
CXCL5/ENA-78
CXCL5, also known as epithelial cell-derived neutrophil-activating peptide (ENA-78), is an 8 kDa proinflammatory member of the CXC subfamily of chemokines. Its Glu-Leu-Arg (ELR) motif confers angiogenic properties and distinguishes it from ELR-CXC chemokines which are angiostatic (1 - 3). Human CXCL5 shares 57% amino acid (aa) sequence identity with mouse and rat CXCL5. Among other human ELR+ chemokines, it shares 77% aa sequence identity with CXCL6/GCP-2 and 35% - 51% with CXCL1/GRO alpha, CXCL2/GRO beta, CXCL3/GRO gamma, CXCL7/NAP-2, and CXCL8/IL-8. Inflammatory stimulation upregulates CXCL5 production in multiple hematopoietic cell types, fibroblasts, endothelial cells, and vascular smooth muscle cells. In vivo, CXCL5 is elevated at sites of inflammation and pulmonary fibrosis where it promotes neutrophil infiltration and activation as well as angiogenesis (3 - 6). Its upregulation contributes to increased vascularization, tumor growth, and metastasis in many cancers (6 - 9). Full length CXCL5 (78 aa) is trimmed at the N-terminus by cathepsin G and chymotrypsin to ENA-74 (74 aa) and ENA-70 (70 aa), with the shortened forms showing increased potency relative to full length CXCL5 (10, 11). CXCL5 exerts its effects primarily through interactions with CXCR2 (6, 12). It also binds duffy antigen receptor for chemokines (DARC), which can limit CXCR2-mediated responses (13, 14).


目次に戻る

Citations

R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
  1. Combination therapy: Synergistic suppression of virus-induced chemokines in airway epithelial cells.
    Authors: Edwards MR, Johnson MW, Johnston SL
    Am. J. Respir. Cell Mol. Biol., 2006;34(5):616-24.
    Species: Human
    Sample Type: Cell Culture Supernates
    Application: ELISA Development

  2. Imbalance in the expression of CXC chemokines correlates with bronchoalveolar lavage fluid angiogenic activity and procollagen levels in acute respiratory distress syndrome.
    Authors: Keane MP, Donnelly SC, Belperio JA, Goodman RB, Dy M, Burdick MD, Fishbein MC, Strieter RM
    J. Immunol., 2002;169(11):6515-21.
    Species: Human
    Sample Type: BALF
    Application: ELISA Development



目次に戻る

お問い合わせ先

(テクニカルサポート 試薬担当)

reagent@funakoshi.co.jp

製品情報は掲載時点のものですが、価格表内の価格については随時最新のものに更新されます。お問い合わせいただくタイミングにより製品情報・価格などは変更されている場合があります。
表示価格に、消費税等は含まれていません。一部価格が予告なく変更される場合がありますので、あらかじめご了承下さい。